Merck & Co., Inc. (BMV:MRK)

Mexico flag Mexico · Delayed Price · Currency is MXN
2,021.38
-88.62 (-4.20%)
Last updated: Feb 9, 2026, 1:51 PM CST
Market Cap5.02T +2.7%
Revenue (ttm)1.17T +1.3%
Net Income328.63B +6.6%
EPS131.06 +8.0%
Shares Outn/a
PE Ratio15.27
Forward PE22.74
Dividend61.71 (3.05%)
Ex-Dividend DateDec 15, 2025
Volume23
Average Volume1,095
Open2,021.38
Previous Close2,110.00
Day's Range2,021.38 - 2,021.38
52-Week Range1,425.00 - 2,126.90
Beta0.30
RSI58.25
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2025, Merck & Co.'s revenue was $65.01 billion, an increase of 1.31% compared to the previous year's $64.17 billion. Earnings were $18.25 billion, an increase of 6.64%.

Financial numbers in USD Financial Statements